In the study, seven compounds were isolated from an EtOAc extract of the marine-derived fungal strain
Xenomyrothecium sp. IMBC-FP2.11, including (3R,4R)-4-hydroxymellein (1), (3R,4S)-4-hydroxymellein (2), trans-3,4-
dihydro-3,4,8-trihydroxynaphtalen-1(2H)-one (3), (3S)-6-hydroxy-8-methoxy-3,5-dimethyl-isochroman (4), 8-hydroxy-
6-methyl-9-oxo-9H-xanthene-1-carboxylate (5), TMC-256A1 (6), and -hydroxyemodin (7). Their chemical structures
were elucidated by detailed analysis of the 1D and 2D NMR and mass spectra as well as comparison with those of the
previously reported compounds. This is the first case to report the chemical profile of a Xenomyrothecium fungal strain.
7 trang |
Chia sẻ: thuyduongbt11 | Ngày: 17/06/2022 | Lượt xem: 272 | Lượt tải: 0
Bạn đang xem nội dung tài liệu Secondary metabolites from a marine sponge-associated fungus Xenomyrothecium sp. IMBC-FP2.11, để tải tài liệu về máy bạn click vào nút DOWNLOAD ở trên
Cite this paper: Vietnam J. Chem., 2020, 58(6), 752-758 Article
DOI: 10.1002/vjch.202000067
752 Wiley Online Library © 2020 Vietnam Academy of Science and Technology, Hanoi & Wiley-VCH GmbH
Secondary metabolites from a marine sponge-associated fungus
Xenomyrothecium sp. IMBC-FP2.11
Tran Hong Quang
1*
, Pham Thi Mai Huong
1
, Nguyen Thi Thanh Ngan
2
, Tran Thi Hong Hanh
1
,
Nguyen Xuan Cuong
1
, Nguyen Hoai Nam
1
, Chau Van Minh
1
1
Institute of Marine Biochemistry, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc
Viet, Cau Giay, Hanoi 10000, Viet Nam
2
Institute of Genome Research, VAST, 18 Hoang Quoc Viet, Cau Giay, Hanoi 10000, Viet Nam
Received April 30, 2020; Accepted July 9, 2020
Abstract
In the study, seven compounds were isolated from an EtOAc extract of the marine-derived fungal strain
Xenomyrothecium sp. IMBC-FP2.11, including (3R,4R)-4-hydroxymellein (1), (3R,4S)-4-hydroxymellein (2), trans-3,4-
dihydro-3,4,8-trihydroxynaphtalen-1(2H)-one (3), (3S)-6-hydroxy-8-methoxy-3,5-dimethyl-isochroman (4), 8-hydroxy-
6-methyl-9-oxo-9H-xanthene-1-carboxylate (5), TMC-256A1 (6), and -hydroxyemodin (7). Their chemical structures
were elucidated by detailed analysis of the 1D and 2D NMR and mass spectra as well as comparison with those of the
previously reported compounds. This is the first case to report the chemical profile of a Xenomyrothecium fungal strain.
Keywords. Xenomyrothecium, marine fungus, isochroman, naphtalenone, xanthone, naphtho--pyrone,
anthraquinone.
1. INTRODUCTION
Marine-derived fungi have been demonstrated as a
rich source of bioactive metabolites with high
diverse chemical structures. Xenomyrothecium
(Stachybotriaceae family) is a monotypic genus
derived from Myrothecium,
[1]
the fungal genus has
been shown to produce various types of secondary
metabolites, including cyclopentenones,
[2]
macrocyclic trichothecenes,
[3-6]
and meroterpenoids
and isocoumarinoids.
[7]
However, chemical profile
of the Xenomyrothecium genus has yet to be
discovered so far. In our continuing search for
secondary metabolites from the Vietnamese marine-
derived fungi,
[8,9]
we conducted a chemical
investigation of a fungal strain Xenomyrothecium sp.
IMBC-FP2.11 isolated from an unidentified sponge.
The present study dealt with isolation and structural
determination of seven compounds from the EtOAc
extract of the fermentation culture of the fungal
strain.
2. MATERIAL AND METHODS
2.1. Fungal material
The fungal strain IMBC-FP2.11 was isolated from
an unidentified sponge collected from Quang Nam
sea, Vietnam during May, 2019. After sterilizing the
surface, a small slice of the sponge sample was
homogenized in sterile seawater. A part of the
mixture was transferred to a potato dextrose agar
(PDA) plate using the spread method and incubated
at 25
o
C over 15 days. The fungal isolates were sub-
cultured and purified to give pure fungal strain
which was preserved at -80
o
C. Taxonomic
classification of the fungal strain was done by
analyzing the ITS region of the fungal rDNA. A
GenBank search using the ITS rDNA gene of
IMBC-FP2.11 (GenBank accession number
MT367734) revealed that Xenomyrothecium
tongaense (NR_154511.1) is the closest match, with
99 % similarity. Consequently, the fungal strain
IMBC-FP2.11 was identified as Xenomyrothecium
sp.
2.2. General experimental procedures
Optical rotations were measured by a Jasco P-2000
digital polarimeter. The NMR spectra were obtained
on Bruker AVANCE III HD 500 FT-NMR and
JEOL JNM ECP-400 FT-NMR spectrometers.
ESIMS were acquired by an ESI Q-TOF MS/MS
system (AB SCIEX Triple). Thin layer
Vietnam Journal of Chemistry Tran Hong Quang et al.
© 2020 Vietnam Academy of Science and Technology, Hanoi & Wiley-VCH GmbH www.vjc.wiley-vch.de 753
chromatography (TLC) was carried out using
Kieselgel 60 F254 and RP-18 F254s plates (Merck).
Column chromatography (CC) was performed using
silica gel (Kieselgel 60, 230-400 mesh, Merck) and
YMC*Gel (ODS-A, 12 nm, S-150 m, YMC Co.,
Ltd.) resins. Preparative high-performance liquid
chromatography (HPLC) was performed on an
Agilent 1200 Preparative HPLC System.
2.3. Fermentation and extraction
The fungal strain Xenomyrothecium sp. IMBC-
FP2.11 was grown on 50 replicate 2L-Erlenmeyer
flasks (each flask contained 100 mL of PDA and 3.0
% NaCl). The seed cultures (2 mL) of the fungal
strain was added to the media and incubated at 25
o
C
for 20 days. Subsequently, the combined agar media
and fungal biomass were extracted three times with
EtOAc (10 L/time) to yield the extract which was
further concentrated in vacuo to give a residue (4.8 g).
2.4. Isolation and identification
The EtOAc extract of Xenomyrothecium sp. IMBC-
FP2.11 was fractionated by reversed phase (RP) C18
flash column chromatography (CC), using a
stepwise gradient elution of 20, 40, 60, 80, and 100
% MeOH in H2O to provide fractions F1-F6,
respectively. Next, fraction F2 was subjected to
sephadex LH-20 CC, eluting with CH2Cl2-MeOH
(15:1, v/v) to yield for subfractions (F2.1-F2.4). F2.4
was then purified by silica gel prep. TLC, using
CH2Cl2-EtOAc (5:1, v/v) to obtain 3 (8 mg). F3 was
introduced to sephadex LH-20 CC, eluting with
MeOH-H2O (4:1, v/v) to provide five subfractions
(F3.1-F3.5). F3.2 was then purified by prep. RP C18
HPLC, using a gradient elution of MeOH (40 to 100
%) in H2O over 60 min to give 4 (2 mg). Using the
similar method, F3.4 was separated by prep. RP C18
HPLC, eluting with 20 % acetonitrile in H2O over 60
min to give 1 (14 mg) and 2 (2 mg). Fraction F4 was
introduced to an RP C18 fractionation, eluting with
MeOH in H2O (1:1 to 2:1, v/v) to provide
subfractions F4.1-F4.4. F4.2 was further purified by
RP C18 prep. HPLC, using a gradient elution of 50-
100 % MeOH in H2O over 60 min to give 7 (5 mg).
By the similar method, compound 6 (2 mg) was
isolated from F4.3 by RP C18 prep. HPLC, using a
gradient elution of MeOH in H2O (60-100 %) over
60 min. Finally, compound 5 (3 mg) was obtained
from F4.4 by silica gel prep. TLC, using n-hexane-
EtOAc (1:6, v/v) as a mobile phase.
(3R,4R)-4-hydroxymellein (1): white,
amorphous powder; []D
25
= -21.5 (c = 0.1, MeOH);
C10H10O4, M = 194; ESIMS: m/z 217 [M+Na]
+
;
1
H
(CD3OD, 500 MHz) and
13
C NMR details (CD3OD,
125 MHz), see table 1.
(3R,4S)-4-hydroxymellein (2): white,
amorphous powder; []D
25
= -16.0 (c = 0.1, MeOH);
C10H10O4, M = 194; ESIMS: m/z 217 [M+Na]
+
;
1
H
(CD3OD, 500 MHz) and
13
C NMR details (CD3OD,
125 MHz), see table 1.
trans-3,4-Dihydro-3,4,8-trihydroxynaphtalen-
1(2H)-one (3): white, amorphous powder; []D
25
=
+31.3 (c = 0.1, MeOH); C10H10O4, M = 194; ESIMS:
m/z 195 [M+H]
+
;
1
H (CD3OD, 400 MHz) and
13
C
NMR details (CD3OD, 100 MHz), see table 2.
(3S)-6-Hydroxy-8-methoxy-3,5-dimethyl-
isochroman (4): white, amorphous powder; []D
25
=
+121.6 (c = 0.2, MeOH); C12H16O3, M = 208;
ESIMS: m/z 209 [M+H]
+
;
1
H (DMSO-d6, 400 MHz)
and
13
C NMR details (DMSO-d6, 100 MHz), see
table 2.
8-hydroxy-6-methyl-9-oxo-9H-xanthene-1-
carboxylate (5): yellow, amorphous powder;
C16H12O5, M = 284; ESIMS: m/z 285 [M+H]
+
;
1
H
(CDCl3, 400 MHz) and
13
C NMR details (CDCl3,
100 MHz), see table 3.
TMC-256A1 (6): yellow, amorphous powder;
C15H12O5, M = 272; ESIMS: m/z 295 [M+Na]
+
;
1
H
(DMSO-d6, 400 MHz) and
13
C NMR details
(DMSO-d6, 100 MHz), see table 3.
-Hydroxyemodin (7): yellow, amorphous
powder; C15H10O6, M = 286; ESIMS: m/z 287
[M+H]
+
;
1
H (DMSO-d6, 400 MHz) and
13
C NMR
details (DMSO-d6, 100 MHz), see table 3.
3. RESULTS AND DISCUSSION
The molecular formula of compound 1, C10H10O4
was deduced by a quasi-molecular ion [M+Na]
+
at
m/z 217 in the ESIMS in combination with an
analysis of its NMR spectroscopic data. Its
1
H NMR
spectrum was shown to contain proton signals
characteristic of an ABC spin system [H 7.00 (d, J
= 8.0 Hz, H-5), 7.57 (t, J = 8.0 Hz, H-6), and 7.00
(d, J = 8.0 Hz, H-7)], suggesting the presence of an
1,2,3-trisubstituted aromatic ring. The
1
H NMR
spectrum additionally showed signals of two
oxymethine groups [H 4.74 (qd, J = 2.0, 6.5 Hz, H-
3) and 4.58 (d, J = 2.5 Hz, H-4)] and one secondary
methyl group at H 1.54 (d, J = 6.5 Hz, H3-9).
Analysis of the
13
C NMR and HSQC spectra of 1
revealed 10 signals, of which one carbonyl group at
C 171.0 (C-1), three non-protonated signals at C
143.2 (C-4a), 162.9 (C- 8), and 108.4 (C-8a), two
oxymethine at C 80.0 (C-3) and 67.7 (C-4), and a
methyl at C 16.3 (C-9) were recognized (table 1).
With the observed
1
H and
13
C NMR spectroscopic
Vietnam Journal of Chemistry Secondary metabolites from
© 2020 Vietnam Academy of Science and Technology, Hanoi & Wiley-VCH GmbH www.vjc.wiley-vch.de 754
Figure 1: Structures of compounds 1-7 from Xenomyrothecium sp. IMBC-FP2.11
Table 1:
1
H and
13
C NMR spectroscopic data for 1 and 2
Position C
#1
1 C
#2
2
C
a,b
H
a,c
(J in Hz) C
a,b
H
a,c
(J in Hz)
1 169.7 171.0 168.5 170.2
3 67.5 80.0 4.74 (qd, 2.0, 6.5) 79.9 81.6 4.56
(qd, 4.5, 6.5)
4 78.8 67.7 4.58 (d, 2.0) 69.1 69.5 4.57
(d, 4.5)
4a 141.0 143.2 141.2 144.1
5 118.9 119.8 7.00 (d, 8.0) 116.2 117.7 7.10 (d, 8.5)
6 137.2 137.7 7.57 (t, 8.0) 136.8 137.8 7.59 (t, 8.5)
7 118.7 118.4 7.00 (d, 8.0) 117.8 117.8 6.96 (d, 8.5)
8 162.3 162.9 161.9 162.9
8a 107.2 108.4 106.6 108.0
9 16.4 16.3 1.54 (d, 6.5) 17.9 18.2 1.49 (d, 6.5)
a
Recorded in CD3OD,
b
125 MHz,
c
500 MHz;
#1δC of (3R,4R)-4-hydroxymellein in CDCl3;
[10]
#2δC of (3R,4S)-4-
hydroxymellein in CDCl3.
[13]
evidence, compound 1 was suggested to be an
isocoumarin derivative. Comparison of the NMR
data of 1 with those of the previously reported
isocoumarin, (3R,4R)-4-hydroxymellein revealed a
good agreement, implying that these compounds
have the identical structures.
[10]
The small coupling
(J = 2.0 Hz) between two vicinal protons (H-3 and
H-4) indicated that these protons have a cis-
relationship.
[10-12]
This was supported by the
agreement between the specific optical rotation of 1
with the previously reported value: 1: []D
25
= -21.5
(c = 0.1, MeOH) vs. (3R,4R)-4-hydroxymellein:
[]D
25
= -39.2 (c = 0.25, MeOH). In addition, the
structure of 1 was confirmed by HMBC correlations
from H3-9 to C-3 and C-4, from H-3 to C-1, C-4, and
C-4a, and from H-7 to C-8 and C-8a (figure 2).
Consequently, compound 1 was identified as
(3R,4R)-4-hydroxymellein.
Compound 2's molecular formula was
established as C10H10O4 by a sodium adduct ion
[M+Na]
+
at m/z 217 observed in the ESI mass
spectrum. Comparison between the NMR data of 2
and 1 resulted in a good agreement, except that the
carbon chemical shifts of C-3, C-4, and C-9 of 2 are
Figure 2: Selected HMBC correlations of
compounds 1, 2, and 4-6
more down-field shifted, at C 81.6, 69.5, and 18.2,
respectively (table 1). In addition, the significant
higher coupling between H-3 and H-4 of 2 (J = 4.5
Hz) compared with that of 1 (J = 2.0 Hz) revealed
that these protons are trans- configured. Thus,
compound 2 was suggested to be adiastereoisomer
of 1. This was further supported by the close
similarity of the
1
H and
13
C NMR data and the
Vietnam Journal of Chemistry Tran Hong Quang et al.
© 2020 Vietnam Academy of Science and Technology, Hanoi & Wiley-VCH GmbH www.vjc.wiley-vch.de 755
specific optical rotation of 2 compared with those of
the previously reported analogs.
[11-13]
Consequently,
the overall structure of 2 was confirmed by detailed
analysis of the HSQC and HMBC spectra (figure 2).
On the basis of thespectroscopic evidence obtained,
compound 2 was elucidated to be (3S,4R)-4-
hydroxymellein.
Compound 3 possessed the molecular formula
C10H10O4, as established by the present of a
protonated molecular ion [M+H]
+
at m/z 195 in the
ESIMS. Its
1
H NMR spectrum showed proton
signals for an ABC spin system [H 6.85 (d, J = 8.0
Hz, H-5), 7.53 (t, J = 8.0 Hz, H-6), and 7.13 (d, J =
8.0 Hz, H-7)], two oxymethine groups at H 4.07 (m,
H-3) and 4.60 (d, J = 6.8 Hz, H-4), and a methylene
group [H 2.70 (dd, J = 8.0, 17.2 Hz, Ha-2) and 3.10
(dd, J = 4.0, 17.2 Hz, Hb-2)]. In the
13
C NMR
spectrum, signals of three non-protonated carbons at
C 145.8 (C-4a), 163.2 (C-8), and 116.7 (C-8a) and
three aromatic methine carbons at C 120.1 (C-5),
137.9 (C-6), and 117.7 (C-7) were observed,
characterizing the presence of a 1,2,3-trisubstituted
benzene ring. The
13
C NMR spectrum additionally
exhibited signals of a carbonyl functional group at
C 204.3 (C-1), two oxymethine carbons at C 71.6
(C-3) and 73.2 (C-4), and a methylene carbon at C
44.3 (C-2). These aforementioned
1
H and
13
C NMR
values allowed to suggest that compound 3 is a
naphthalenone derivative. Accordingly, the
1
H NMR
spectroscopic data of 3 was identical with those of
the previously reported naphthalenone, trans-3,4-
dihydro-3,4,8-trihydroxynaphtalen-1(2H)-one,
suggesting the identical structures of both
compounds (table 2).
[14]
The trans-relationship
between H-3 and H-4 of 3 was deduced from their
relative large vicinal couplings (J = 6.8 Hz) which
were consistent with those of the reported compound
(Table 2).
[14]
On the basis of the aforementioned
analysis, compound 3 was identified as trans-3,4-
dihydro-3,4,8-trihydroxynaphtalen-1(2H)-one.
The molecular formula of compound 4,
C10H14O4 was deduced by a quasi-molecular ion
[M+H]
+
at m/z 209 in the ESIMS. The
1
H NMR
spectrum of 4 exhibited a singlet of an aromatic
proton at H 6.31 (H-7), implying the presence of a
penta-substituted benzene ring. The
1
H NMR
spectrum additionally displayed two methyl signals
at H 1.25 (d, J = 6.4 Hz, C-3) and 1.91 (s) and one
methoxy signal at H 3.65 (s, 8-OCH3). The
13
C
NMR and DEPT spectra of 4 contained six sp
2
[including three aromatic non-protonated carbons at
C 112.7 (C-5), 153.8 (C-6), and 153.0 (C-8)] and
six sp
3
carbons [including one oxymethine at C 69.8
(C-3), one oxymethylene at C 63.7 (C-1), and one
methylene at C 33.5 (C-4)] (table 2). This
spectroscopic evidence led to a hypothesis that 4 has
the isochroman skeleton type. Accordingly, the
1
H
and
13
C NMR data of 4 were in a good match
compared with those of the reported isochroman
derivative, (3S)-6-hydroxy-8-methoxy-3,5-
dimethylisochroman, indicating that their structures
are identical.
[15]
Subsequently, the structure of 4 was
confirmed by HMBC spectrum. An HMBC
correlation observed from H 3.65 to C 153.0 (C-8)
revealed that the methoxy group is located at C-8
(figure 2). Furthermore, HMBC correlations from
Table 2:
1
H and
13
C NMR data for compounds 3 and 4
Position H
#1
(J in Hz)
3 C
#2
4
C
a,b
H
a,c
(J in Hz) C
d,b
H
d,c
(J in Hz)
1 204.3 64.6 63.7 4.66 (d, 14.4)
4.40 (d, 14.4)
2 2.72 (dd, 8.0, 17.2)
3.11 (dd, 4.0, 17.2)
44.3 2.70 (dd, 8.0, 17.2)
3.10 (dd, 4.0, 17.2)
3 4.05-4.11 (m) 71.6 4.07 (m) 70.6 69.8 3.60 (m)
4 4.63 (d, 7.0) 73.2 4.60 (d, 6.8) 34.0 33.5 2.58 (dd, 2.8, 16.0)
2.26 (dd, 10.0, 16.0)
4a 145.8 134.1 133.6
5 6.88 (dd, 0.6, 8.6) 120.1 6.85 (d, 8.0) 112.9 112.7
6 7.56 (dd, 7.4, 8.4) 137.9 7.53 (t, 8.0) 152.7 153.8
7 7.14 (dt, 0.6, 7.4) 117.7 7.13 (d, 8.0) 96.2 95.9 6.31 (s)
8 163.2 153.9 153.0
8a 116.7 115.2 113.7
9 21.7 21.6 1.25 (d, 6.4)
10 10.0 10.0 1.91 (s)
8-OCH3 55.0 54.8 3.65 (s)
a
Recorded in CD3OD,
b
100 MHz,
c
400 MHz,
d
in DMSO-d6;
#1δH of trans-3,4-dihydro-3,4,8-trihydroxynaphtalen-
1(2H)-one in CD3OD;
[14]
#2δC of (3S)-6-hydroxy-8-methoxy-3,5-dimethylisochroman in CDCl3.
[15]
Vietnam Journal of Chemistry Secondary metabolites from
© 2020 Vietnam Academy of Science and Technology, Hanoi & Wiley-VCH GmbH www.vjc.wiley-vch.de 756
H3-9 to C-3 and C-4 and from H3-10 to C-4a, C-5,
and C-6 enabled to confirm the position 9-CH3
and10-CH3, respectively. Thus, compound 4 was
identified as (3S)-6-hydroxy-8-methoxy-3,5-
dimethylisochroman.
The molecular formula of compound 5,
C16H12O5 was established based on a protonated
molecular ion [M+H]
+
at m/z 285 in the ESIMS. In
the
1
H NMR spectrum, aromatic proton signals for a
1,2,3-trisubstituted benzene ring [H 7.31 (d, J = 8.0
Hz, C-2), 7.73 (t, J = 8.0 Hz, C-3), and 7.52 (d, J =
8.0 Hz, C-4)] and a 1,2,3,5-tetrasubstituted aromatic
ring [H 6.74 (br s, H-5) and 6.63 (br s, H-7)], along
with singlet signals of a methyl at H 2.42 (6-CH3)
and a methoxy at H 4.02 (1-COOCH3) (Table 3).
Analysis of the
13
C NMR and DEPT spectra pointed
out 16 signals, including two carbonyl carbons at C
180.4 (C-9) and 169.7 (1-COOCH3), seven aromatic
non-protonated carbons [including three oxygenated
carbons at C 161.5 (C-8), 156.0 (C-4a), and 155.7
(C-4b) ]. This
1
H and
13
C NMR evidence suggests
that 5 belongs to the xanthone skeleton type. This
was supported by comparing the NMR data of 5
with those of the previously reported xanthone, 8-
hydroxy-6-methyl-9-oxo-9H-xanthene-1-
carboxylate (table 3).
[16,17]
In the HMBC spectrum,
cross-peaks from H 12.14 (8-OH) to C-7, C-8, and
C-8a, from H 4.02 (1-COOCH3) to C-1, from H-2 to
C-1, and from H 2.42 (6-CH3) to C-6 were
observed, thus confirming the gross structure of 5
(figure 2). Therefore, compound 5 was determined
to be 8-hydroxy-6-methyl-9-oxo-9H-xanthene-1-
carboxylate.
Compound 6 had the molecular formula
C10H10O4, as determined by the ESIMS. In the
1
H
NMR spectrum of 6, proton signals of two meta-
coupled protons were observed at H 6.42 and 6.64
(each d, J = 2.0 Hz, H-7 and H-9), implying the
existence of a 1,2,3,5-tetrasubstituted aromatic ring.
In addition, a singlet signal at H 7.03 (s, H-10)
implying a penta-substituted benzene ring, one
methyl group at H 2.36 (s, 2-CH3), one methoxy
group at H 3.85 (s, 6-OCH3), and one olefinic
proton at H 6.15 (s, H-3) were also recognized. The
13
C NMR and DEPT spectra displayed signals of 15
carbons, including one carbonyl carbon at C 183.6
(C-4) and eight aromatic non-protonated carbons
[including five carbons-bearing oxygen at C 168.4
(C-2), 162.3 (C-5), 160.6 (C-6), 160.0 (C-8), and
152.4 (C-10a)]. On the basis of the observed
1
H and
Table 3:
1
H and
13
C NMR data for compounds 5-7
Position C
#1
5
C
#2
6
C
#3
7
C
a,b
H
a,c
(J in Hz) C
d,b
H
d,c
(J in Hz) C
d,b
H
d,c
(J in Hz)
1 133.6 133.6 162.6 161.4
2 122.5 122.4 7.31 (d, 8.0) 168.3 168.4 120.9 120.7 7.25 (s)
3 134.8 134.7 7.73 (t, 8.0) 106.5 106.5 6.15 (s) 153.1 152.8
4 119.4 119.4 7.52 (d, 8.0) 183.5 183.6 117.3 117.1 7.65 (s)
4a 156.0 156.0 102.8 102.8 131.2 132.9
4b 155.7 155.7
5 107.4 107.4 6.74 (br s) 162.2 162.3 109.0 108.8 7.14 (d, 2.0)
5a 106.5 106.5
6 149.4 149.4 160.5 160.6 165.5 165.6
7 111.7 111.7 6.63 (br s) 97.4 97.5 6.42 (d, 2.0) 108.1 107.8 6.61 (d, 2.0)
8 161.5 161.5 159.9 160.0 165.7 164.4
8a 107.0 107.0 109.7 109.0
9 180.4 180.4 101.0 101.0 6.64 (d, 2.0) 191.0 189.7
9a 117.6 117.6 140.8 140.8 114.4 114.1
10 99.7 99.8 7.03 (s) 181.4 181.4
10a 152.4 152.4 133.6 135.2
1-COOCH3 169.7 169.7
1-COOCH3 53.1 53.2 4.02 (s)
1-OH 12.09 (s)
2-CH3 20.0 20.1 2.36 (s)
3-CH2OH 62.9 62.0 4.61 (s)
6-CH3 22.6 22.6 2.42 (s)
6-OCH3 55.6 55.7 3.85 (s)
8-OH 12.14 (s)
a
Recorded in CDCl3,
b
100 MHz,
c
400 MHz,
d
in DMSO-d6;
#1δC of